Join our community of smart investors

Zotefoams' ReZorce packaging could be transformational

The company will seek investment partners if the material makes it through trials
March 19, 2024
  • Operating profit up 9 per cent
  • Core business makes decent start to 2024

In an otherwise steady set of results, much of the buzz (and the money being spent) at Zotefoams (ZTF) centres on the ReZorce product under development by its MuCell Extrusion arm.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in